RecruitingNCT06487754
New-onset Chronic Pelvic Pain in Transgender People Using Testosterone Therapy: an Exploratory Qualitative Study.
Sponsor
University Hospital, Grenoble
Enrollment
15 participants
Start Date
Sep 27, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This descriptive qualitative study aim to describe the characteristics of pelvic pain in transgender (trans) individuals using testosterone therapy and the impact on their quality of life. This study also aim to understand the levers and obstacles to consulting a health care professional.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Being a trans masculine individual
- Taking a gender affirming hormonal therapy (GAHT)
- living close to Grenoble
- having pelvic pain that appeared or were modified after taking GAHT
Exclusion Criteria1
- Subject under guardianship or subject deprived of liberty Refusal of voice recording
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06487754
Related Trials
Effect of Alcohol Sclerotherapy on Pelvic Pain and Quality of Life in Women With Ovarian Endometriosis
NCT0695522127 locations
Quantify the Degree of Pain Relief of Pelvic Congestion Syndrome Following Gonadal Vein Embolization
NCT037944661 location
TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men
NCT074609601 location
Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices
NCT061680583 locations
Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy
NCT060595863 locations